Por: The New York Times Health March 11, 2023
The Food and Drug Administration has approved a Pfizer nasal spray for treatment of migraines that uses a different therapy from other nasal products on the market for severe headache pain, the company said on Friday.The fast-acting treatment, which is called zavegepant and will be sold as Zavzpret, performed better than a placebo in relieving pain and patients’ most bothersome symptoms, according to published in the journal Lancet Neurology.... + full article
ABC7 USA Health March 11, 2023
The U.S. Food and Drug Administration has approved Pfizer's newest drug on the migraine market, Zavzpret (zavegepant) - the first and only migraine treatment of its kind to be offered in nasal spray.The drug has shown in clinical trial data to provide rapid pain relief in... + más
FDA approves Prizer's Zavzpret, first of its kind migraine treatment nasal spray | ABC7
FDA approves Pfizer's new nasal spray treatment for migraines | ABC News
ABC News USA Health March 11, 2023
The U.S. Food and Drug Administration has approved Pfizer's newest drug on the market, Zavzpret (zavegepant) -- the first and only migraine treatment of its kind to be offered in nasal spray.The drug has shown in clinical trial data to provide rapid pain relief in as fast... + más
F.D.A. Approves New Nasal Spray for Migraines | The New York Times
FDA Approves a New Nasal Spray to Treat Migraines | Time
WPTV USA Nation March 11, 2023
People who suffer from migraines will have another option to get relief. The Food and Drug Administration approved Pfizer's Zavzpret this week. Pfizer says it's the first nasal spray approved to block calcitonin gene-related peptide, a protein believed to contribute... + más
Time USA Health March 10, 2023
On Mar. 10, the U.S. Food and Drug Administration (FDA) a new treatment for migraines given as a nasal spray, according to the drug’s maker, Pfizer. Zavegepant (brand name: Zavzpret), is the first of a class of migraine treatments known as calcitonin gene-related peptide... + más
ABC News USA Life January 21, 2023
has revealed what sent her 14-year-old daughter to the emergency room twice in recent weeks.Spelling, a mom of five, that her daughter Stella suffered symptoms resembling those of a stroke, including severe numbness in her left arm, mouth and throat.Her left arm went completely... + más
Tori Spelling says her daughter Stella, 14, is home from the hospital after suffering a 'Hemiplegic Migraine' | Fox News
Tori Spelling shares update on daughter Stella's condition after two hospitalizations: 'Not great' | Fox News
Politico USA Health October 15, 2022
Biden administration officials are raising concerns that the slow pace of developing a nasal vaccine for Covid-19 in the U.S. could pose a security risk as China, Iran and Russia approve their own vaccines taken through the nose or mouth. Though nasal and oral vaccines are being... + más
Nasal COVID vaccine blows clinical trial, flinging researchers back to the lab | Ars Technica
Nasal COVID vaccine fails to offer desired protection in testing | The Hill
About iurex | Privacy Policy | Disclaimer |